Interchange
Merck Sponsors the Interchange
Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada.
Through its prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, it work with customers and operate in more than 140 countries to deliver innovative health solutions. It also demonstrate its commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
Learn more about how agencies and industry fight medicine counterfeiting and sales at the 2011 Interchange on October 27 at the National Press Club.
Alex Dahl to Speak on Panel at The Partnership for Safe Medicines Interchange 2011
Alex Dahl will speak on the panel, “Protecting Our Medicines.” He is a member of The Coalition for Patient Safety and Medicine Integrity which is a group of pharmaceutical, medical device and medical products companies focused on patient safety.
Its purpose is to protect patients from the risks posed by stolen and inappropriately handled medical products re-entering the legitimate supply chain. The Coalition includes: Abbott Laboratories, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Novo Nordisk, Sanofi Aventis, and PhRMA.
Teva Pharmaceutical Industries Sponsors Partnership for Safe Medicines Interchange 2011
Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world’s largest generic drug maker, with a global product portfolio of more than…
[...]Amgen Sponsors the Partnership for Safe Medicines Interchange
Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in…
[...]Xuanhao Chan To Speak On Panel at Interchange
Xuanhao Chan, lead technical officer for the International Pharmaceutical Federation, will join panelists on “The role of Patients and Healthcare Professionals” at the Partnership for Safe Medicine Interchange on October 27, 2011.
Chan is a registered pharmacist from Singapore and for the past 6 years, he has been working for the International Pharmaceutical Federation (FIP) in various positions. More recently, in 2008 he established the first branch office for FIP in Geneva managing the Federation’s global public health partnerships and serves as the FIP advocacy focal point with the World Health Organization (WHO) and other international health-related agencies in Geneva, Switzerland.
Lilly, Sponsor of the Partnership for Safe Medicines Interchange 2011
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs. Learn more about…
[...]Pfizer, Sponsor of the Partnership for Safe Medicines Interchange
Pfizer applies science and global resources to improve health and well-being at every stage of life. They strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Their diversified global health care portfolio includes human and animal biologic and small molecule medicines and…
[...]Keynote Speaker Announced for Interchange
John Morton will be the keynote speaker for The Partnership for Safe Medicine’s Interchange on October 27, 2011 at the National Press Club.
Morton is the Director of Immigration and Customs Enforcement (ICE), the principal investigative arm of the U.S. Department of Homeland Security and the second largest investigative agency in the federal government. During his tenure at ICE, he has strengthened ICE’s investigative efforts, with a particular emphasis on border crimes, export controls, intellectual property enforcement and child exploitation.
Sproxil, Sponsor of the Partnership for Safe Medicines Interchange
Sproxil provides world-class brand protection for emerging markets through software and services that work anywhere there are mobile phones. Delivering automatic protection, simple labels and robust back-end analytics with its Mobile Product AuthenticationTM (MPA) solution, Sproxil offers a comprehensive anti-counterfeiting strategy for cash-based societies, one that enables consumers to text message an item-unique code for…
[...]Jeremiah Mwangi, Policy and External Affairs Director of IAPO
Listening to the thought leaders of safe medicinesat the 2010 Interchange Jeremiah Mwangi, Policy and External Affairs Director of International Alliance of Patients’ Organizations (IAPO), will sit on “The Role of Patients and Healthcare Professionals” panel at 1:45pm at the Partnership for Safe Medicine’s Interchange on October 27, 2011 at the National Press Club in…
[...]